JPH09268178A - Optically active 4,5-diphenyl-2-imidazolidinone derivative - Google Patents
Optically active 4,5-diphenyl-2-imidazolidinone derivativeInfo
- Publication number
- JPH09268178A JPH09268178A JP8078684A JP7868496A JPH09268178A JP H09268178 A JPH09268178 A JP H09268178A JP 8078684 A JP8078684 A JP 8078684A JP 7868496 A JP7868496 A JP 7868496A JP H09268178 A JPH09268178 A JP H09268178A
- Authority
- JP
- Japan
- Prior art keywords
- diphenyl
- imidazolidinone
- amines
- mmol
- optically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は光学純度分析用試
薬、特に不斉炭素を有するアミン類の光学純度分析用試
薬として有用な化合物及びこれを用いる光学純度分析法
に関する。TECHNICAL FIELD The present invention relates to a compound useful as a reagent for optical purity analysis, particularly as a reagent for optical purity analysis of amines having asymmetric carbon atoms, and an optical purity analysis method using the same.
【0002】[0002]
【従来の技術】不斉炭素を有する有機化合物には、エナ
ンチオマー(鏡像異性体)が存在する。そして、香料や
食品添加物では両エナンチオマーによって臭いや味が異
なり、医薬品ではサリドマイドの例に如実に示されてい
るように両異性体によって、薬効や毒性が大きく異な
る。また、強誘電性液晶では純粋なキラル分子構造が求
められており、純度の低下は顕著な機能の低下をもたら
すとされている。このような理由から医薬、農薬、香
料、食品添加物、エレクトロニクス等の産業分野では、
光学純度の高い光学活性化合物が求められており、同時
に正確な光学純度決定法が重要となってきている。2. Description of the Related Art Enantiomers (enantiomers) exist in organic compounds having an asymmetric carbon. And in flavors and food additives, the odors and tastes differ depending on both enantiomers, and in pharmaceuticals, the drug efficacy and toxicity differ greatly depending on both isomers, as is clearly shown in the example of thalidomide. Further, a ferroelectric liquid crystal is required to have a pure chiral molecular structure, and a decrease in purity is said to cause a remarkable decrease in function. For these reasons, in the industrial fields such as medicine, agricultural chemicals, fragrances, food additives, and electronics,
Optically active compounds with high optical purity are required, and at the same time, accurate methods for determining optical purity are becoming important.
【0003】従来知られている光学純度決定法として
は、旋光度の測定による方法、NMRを用いる方法、ク
ロマトグラフィーを用いる方法等が挙げられるが、特に
NMRを用いる方法は測定条件の設定が容易であり適用
範囲が広いことから汎用されている。そして、例えば光
学活性なアミン類の光学純度をNMRによる方法で決定
する場合、光学活性シフト試薬やキラルな溶媒和試薬を
添加することにより、あるいはアミン類をジアステレオ
マーに導くことにより分離した各異性体のシグナルの積
分値を比較することによって行われる。Conventionally known methods for determining optical purity include a method by measuring optical rotation, a method using NMR, a method using chromatography and the like. Particularly, in the method using NMR, the setting of measurement conditions is easy. It is widely used because of its wide application range. Then, for example, in the case of determining the optical purity of optically active amines by a method by NMR, each separated by adding an optically active shift reagent or a chiral solvating reagent, or by introducing the amines into diastereomers. This is done by comparing the integrated values of the isomer signals.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、トリス
〔3−ヘプタフルオロブタノイル−d−カンホラト〕ユ
ウロピウム(III)〔Eu(hfc)3〕に代表される光
学活性シフト試薬は高価であり、またOH基やNH基を
もつ不純物に配位しやすく光学純度の悪いサンプルの鏡
像体のシグナルが分離しない場合がある。キラルな溶媒
和試薬を添加する方法としては、Pirkleの試薬、
(R)−(−)2,2,2−トリフルオロ−1−(9−
アンスリル)エタノール等が知られているが、期待した
シフト効果が得られない場合がある。また、アミンをジ
アステレオマーに導きジアステレオマー比を測定する方
法としては、α−メトキシ−α−トリフルオロフェニル
酢酸(MTPA)の酸クロリドを用いる方法が知られて
いるが、酸クロリドの市販品がなく酸クロリドを調製す
る操作が必要であり、酸クロリドが不安定であるため試
薬の長期保存ができないという欠点があった。However, an optical activity shift reagent represented by tris [3-heptafluorobutanoyl-d-camphorato] europium (III) [Eu (hfc) 3 ] is expensive and OH is high. In some cases, the signal of the enantiomer of the sample, which is likely to be coordinated to the impurities having a group or NH group and has poor optical purity, is not separated. As a method of adding a chiral solvating reagent, a reagent of Pirkle,
(R)-(-) 2,2,2-trifluoro-1- (9-
Although anthryl) ethanol and the like are known, the expected shift effect may not be obtained in some cases. Further, as a method for introducing an amine into a diastereomer and measuring a diastereomer ratio, a method using an acid chloride of α-methoxy-α-trifluorophenylacetic acid (MTPA) is known, but a commercially available acid chloride is used. There was a drawback that the reagent could not be stored for a long period of time because the acid chloride was unstable and the acid chloride was unstable.
【0005】従って、本発明の目的はアミン類の光学純
度を容易に決定することのできる安価な試薬及び光学純
度分析法を提供することにある。Therefore, it is an object of the present invention to provide an inexpensive reagent and an optical purity analysis method capable of easily determining the optical purity of amines.
【0006】[0006]
【課題を解決するための手段】かかる実情において、本
発明者らはアミン類の光学純度の新たな決定法を開発す
べく鋭意研究を行った結果、下記一般式(1)で表され
る新規な光学活性な4,5−ジフェニル−2−イミダゾ
リジノン誘導体とアミン類を縮合することによりジアス
テレオマーとして得られるチオ尿素誘導体が、通常のN
MR測定によりシグナルの分離が可能であり、ジアステ
レオマー比を測定することにより容易に当該アミン類の
光学純度を決定することができることを見出し、本発明
を完成した。Under such circumstances, the present inventors have conducted earnest research to develop a new method for determining the optical purity of amines, and as a result, a novel compound represented by the following general formula (1) A thiourea derivative obtained as a diastereomer by condensing an optically active 4,5-diphenyl-2-imidazolidinone derivative with an amine is
The inventors have found that signals can be separated by MR measurement, and that the optical purity of the amines can be easily determined by measuring the diastereomer ratio, and completed the present invention.
【0007】すなわち、本発明は一般式(1)That is, the present invention has the general formula (1)
【0008】[0008]
【化2】 Embedded image
【0009】〔式中、R1 はアルキル基を示し、R2 は
アルキレン基を示し、lは0又は1の数を示し、*は不
斉炭素の位置を示す)で表される光学活性な4,5−ジ
フェニル−2−イミダゾリジノン誘導体を提供するもの
である。[Wherein R 1 represents an alkyl group, R 2 represents an alkylene group, l represents a number of 0 or 1, and * represents a position of an asymmetric carbon]. The present invention provides a 4,5-diphenyl-2-imidazolidinone derivative.
【0010】また、本発明は一般式(1)で表される
4,5−ジフェニル−2−イミダゾリジノン誘導体を含
有することを特徴とする不斉炭素を有するアミン類の光
学純度分析用試薬を提供するものである。The present invention also contains a 4,5-diphenyl-2-imidazolidinone derivative represented by the general formula (1), characterized in that it contains an asymmetric carbon-containing amine for optical purity analysis. Is provided.
【0011】さらにまた、本発明は一般式(1)で表さ
れる光学活性な4,5−ジフェニル−2−イミダゾリジ
ノン誘導体に不斉炭素を有するアミン類を反応させ、得
られるチオ尿素誘導体を核磁気共鳴スペクトル分析(N
MR)に付すことを特徴とする不斉炭素を有するアミン
類の光学純度分析法を提供するものである。Furthermore, the present invention is a thiourea derivative obtained by reacting an optically active 4,5-diphenyl-2-imidazolidinone derivative represented by the general formula (1) with an amine having an asymmetric carbon. Nuclear magnetic resonance spectrum analysis (N
The present invention provides an optical purity analysis method for amines having an asymmetric carbon, which is characterized by being subjected to MR).
【0012】[0012]
【発明の実施の形態】本発明の4,5−ジフェニル−2
−イミダゾリジノン誘導体は前記一般式(1)で表され
るものであり、式中のR1 で示されるアルキル基として
は炭素数1〜20の直鎖又は分岐鎖のアルキル基が挙げ
られるが、特に炭素数1〜6の直鎖又は分岐鎖のアルキ
ル基が好ましい。当該R1 の具体例としてはメチル基、
エチル基、n−プロピル基、イソプロピル基、n−ブチ
ル基、tert−ブチル基等が挙げられる。R2 で示さ
れるアルキレン基としては、炭素数1〜8の直鎖又は分
岐鎖のアルキレン基が挙げられるが、特に炭素数1〜4
の直鎖アルキレン基が好ましい。BEST MODE FOR CARRYING OUT THE INVENTION The 4,5-diphenyl-2 of the present invention
The imidazolidinone derivative is represented by the general formula (1), and the alkyl group represented by R 1 in the formula includes a linear or branched alkyl group having 1 to 20 carbon atoms. In particular, a linear or branched alkyl group having 1 to 6 carbon atoms is preferable. As a specific example of the R 1, a methyl group,
Examples thereof include ethyl group, n-propyl group, isopropyl group, n-butyl group and tert-butyl group. Examples of the alkylene group represented by R 2 include linear or branched alkylene groups having 1 to 8 carbon atoms, particularly 1 to 4 carbon atoms.
The linear alkylene group of is preferable.
【0013】本発明化合物(1)は、例えば次の反応
(a)又は反応(b)に従って製造することができる。The compound (1) of the present invention can be produced, for example, according to the following reaction (a) or reaction (b).
【0014】[0014]
【化3】 Embedded image
【0015】(式中、R3 はアルキル基を示し、X1、
X2、X3 及びX4 はそれぞれハロゲン原子を示し、M
はアルカリ金属原子を示し、R1 及びR2 は前記と同
じ)(In the formula, R 3 represents an alkyl group, and X 1 ,
X 2 , X 3 and X 4 each represent a halogen atom, and M
Represents an alkali metal atom, and R 1 and R 2 are the same as above)
【0016】すなわち、1,2−ジフェニル−1,2−
エタンジアミン(2)に尿素(3)を反応させて4,5
−ジフェニル−2−イミダゾリジノン(4)を得(工程
1)、これにアシルハライド(5)を反応させて1−ア
シル体(6)となし(工程2)、これをアルキル化して
1−アシル−3−アルキル体(8)となし(工程3)、
これを加水分解してアシル基を脱離せしめて(工程
4)、これにハロゲノカルボン酸ハロゲニド(10)を
反応させてハロゲノアシル−4,5−ジフェニル−2−
イミダゾリジノン誘導体(11)を得(工程5)、次い
でこれにチオシアン酸金属塩(12)を反応させる(工
程6)ことによりチオシアナトアシル体(1a)が製造
される。That is, 1,2-diphenyl-1,2-
Reaction of ethanediamine (2) with urea (3) 4,5
-Diphenyl-2-imidazolidinone (4) was obtained (step 1), and this was reacted with an acyl halide (5) to give a 1-acyl compound (6) (step 2), which was alkylated to 1-. No acyl-3-alkyl derivative (8) (step 3),
This is hydrolyzed to eliminate the acyl group (step 4), and this is reacted with a halogenocarboxylic acid halogenide (10) to give a halogenoacyl-4,5-diphenyl-2-.
A thiocyanatoacyl derivative (1a) is produced by obtaining an imidazolidinone derivative (11) (step 5) and then reacting this with a metal thiocyanate (12) (step 6).
【0017】以下、上記反応を工程毎に説明する。 (1)工程1 光学活性な1,2−ジフェニル−1,2−エタンジアミ
ン(2)を尿素(3)及び水を用いて閉環させることに
より4,5−ジフェニル−2−イミダゾリジノン(4)
が得られる。原料として用いられる光学活性な1,2−
ジフェニル−1,2−エタンジアミン(2)としては、
(1R,2R)−1,2−ジフェニル−1,2−エタン
ジアミン、(1S,2S)−1,2−ジフェニル−1,
2−エタンジアミン等が挙げられる。この反応は、水を
留去しながら加熱することにより行われる。The above reaction will be described below step by step. (1) Step 1 Optically active 1,2-diphenyl-1,2-ethanediamine (2) is cyclized with urea (3) and water to give 4,5-diphenyl-2-imidazolidinone (4). )
Is obtained. Optically active 1,2-used as raw material
As diphenyl-1,2-ethanediamine (2),
(1R, 2R) -1,2-diphenyl-1,2-ethanediamine, (1S, 2S) -1,2-diphenyl-1,
2-ethanediamine etc. are mentioned. This reaction is carried out by heating while distilling off water.
【0018】(2)工程2 4,5−ジフェニル−2−イミダゾリジノン(4)にプ
ロピオニルクロライドに代表される脂肪酸ハロゲニド
(5)を反応させることにより1−アシル−4,5−ジ
フェニル−2−イミダゾリジノン(7)が得られる。こ
の反応は、水素化ナトリウム等の塩基の存在下に行われ
る。(2) Step 2 1-acyl-4,5-diphenyl-2 by reacting 4,5-diphenyl-2-imidazolidinone (4) with fatty acid halogenide (5) represented by propionyl chloride. -Imidazolidinone (7) is obtained. This reaction is carried out in the presence of a base such as sodium hydride.
【0019】(3)工程3 1−アシル−4,5−ジフェニル−2−イミダゾリジノ
ン(7)にハロゲン化アルキル(8)を反応させること
により3−アシル−1−アルキル−4,5−ジフェニル
−2−イミダゾリジノン(9)が得られる。ハロゲン化
アルキル(8)の具体例としては、ヨウ化メチル、ヨウ
化エチル、臭化エチル、ヨウ化n−プロピル、臭化n−
プロピル、塩化n−プロピル、ヨウ化i−プロピル、臭
化i−プロピル、ヨウ化n−ブチル、臭化n−ブチル、
ヨウ化i−ブチル、臭化i−ブチル、塩化t−ブチル等
が挙げられる。この反応は、水素化ナトリウム等の塩基
の存在下に行われる。(3) Step 3 3-acyl-1-alkyl-4,5- by reacting 1-acyl-4,5-diphenyl-2-imidazolidinone (7) with alkyl halide (8). Diphenyl-2-imidazolidinone (9) is obtained. Specific examples of the alkyl halide (8) include methyl iodide, ethyl iodide, ethyl bromide, n-propyl iodide, and n-bromide.
Propyl, n-propyl chloride, i-propyl iodide, i-propyl bromide, n-butyl iodide, n-butyl bromide,
Examples thereof include i-butyl iodide, i-butyl bromide and t-butyl chloride. This reaction is carried out in the presence of a base such as sodium hydride.
【0020】(4)工程4 3−アシル−1−アルキル−4,5−ジフェニル−2−
イミダゾリジノン(9)を加水分解すれば1−アルキル
−4,5−ジフェニル−2−イミダゾリジノン(10)
が得られる。この反応は、ナトリウムメトキシド等の塩
基の存在下にアシル基のみが脱離する条件下で行われ
る。(4) Step 4 3-Acyl-1-alkyl-4,5-diphenyl-2-
Hydrolysis of imidazolidinone (9) yields 1-alkyl-4,5-diphenyl-2-imidazolidinone (10)
Is obtained. This reaction is carried out under the condition that only an acyl group is eliminated in the presence of a base such as sodium methoxide.
【0021】(5)工程5 1−アルキル−4,5−ジフェニル−2−イミダゾリジ
ノン(10)にハロゲノカルボン酸ハロゲニド(11)
を反応させることによりハロゲノアシル−4,5−ジフ
ェニル−2−イミダゾリジノン誘導体(12)が得られ
る。ハロゲノカルボン酸ハロゲニドの具体例としては、
クロルアセチルクロライド、ブロモアセチルクロライド
等が挙げられる。この反応は、ジメチルホルムアミド、
テトラヒドロフラン、ジエチルエーテル等の不活性溶媒
中、n−ブチルリチウム、リチウムジイソプロピルアミ
ド等の有機金属化合物や水素化ナトリウム、水素化リチ
ウム等を用いて化合物(10)の金属塩を調製し、室温
あるいは冷却下に化合物(10)の金属塩の溶液をハロ
ゲノカルボン酸ハロゲニド(11)の溶液中に滴下する
ことにより行われる。(5) Step 5 1-Alkyl-4,5-diphenyl-2-imidazolidinone (10) is converted to halogenocarboxylic acid halogenide (11).
The halogenoacyl-4,5-diphenyl-2-imidazolidinone derivative (12) is obtained by reacting Specific examples of the halogenocarboxylic acid halogenide include:
Examples thereof include chloroacetyl chloride and bromoacetyl chloride. This reaction is carried out by dimethylformamide,
A metal salt of compound (10) is prepared using an organometallic compound such as n-butyllithium or lithium diisopropylamide or sodium hydride or lithium hydride in an inert solvent such as tetrahydrofuran or diethyl ether, and then cooled to room temperature or cooled. It is carried out by dropping a solution of the metal salt of the compound (10) into the solution of the halogenocarboxylic acid halogenide (11) below.
【0022】(6)工程6 ハロゲノアシル−4,5−ジフェニル−2−イミダゾリ
ジノン誘導体(12)にチオシアン酸金属塩(13)を
反応させることにより本発明化合物(1a)が得られ
る。チオシアン酸金属塩(13)の具体例としては、チ
オシアン酸カリウム、チオシアン酸ナトリウム、チオシ
アン酸リチウム等が挙げられる。この反応は、化合物
(12)とチオシアン酸金属塩(13)をエタノール、
メタノール、ジメチルホルムアミド等の溶媒に溶解し、
加熱することにより行われる。(6) Step 6 The compound (1a) of the present invention is obtained by reacting the halogenoacyl-4,5-diphenyl-2-imidazolidinone derivative (12) with the metal thiocyanate (13). Specific examples of the metal thiocyanate (13) include potassium thiocyanate, sodium thiocyanate, lithium thiocyanate and the like. In this reaction, the compound (12) and the metal thiocyanate (13) are treated with ethanol,
Dissolved in a solvent such as methanol or dimethylformamide,
It is performed by heating.
【0023】[0023]
【化4】 Embedded image
【0024】(式中、X5 はハロゲン原子を示し、R1
及びR2 は前記と同じ)(In the formula, X 5 represents a halogen atom, and R 1
And R 2 is the same as above)
【0025】すなわち、1−アルキル−4,5−ジフェ
ニル−2−イミダゾリジノン(9)にN−ハロゲノアル
キルフタルイミド(13)を反応させて化合物(14)
を得(工程7)、これに抱水ヒドラジンを反応させて化
合物(15)となし(工程8)、次いでこれに二硫化炭
素を反応させる(工程9)ことにより、チオシアナトア
ルキル体(1b)が製造される。That is, 1-alkyl-4,5-diphenyl-2-imidazolidinone (9) is reacted with N-halogenoalkylphthalimide (13) to give compound (14).
Was obtained (step 7), and this was reacted with hydrazine hydrate to give compound (15) (step 8), and then this was reacted with carbon disulfide (step 9) to give the thiocyanatoalkyl compound (1b). ) Is manufactured.
【0026】以下、上記反応を工程毎に説明する。 (1)工程7 1−アルキル−4,5−ジフェニル−2−イミダゾリジ
ノン(9)にN−ハロゲノアルキルフタルイミド(1
3)を反応させることによりフタルイミドアルキル−
4,5−ジフェニル−2−イミダゾリジノン誘導体(1
4)が得られる。N−ハロゲノアルキルフタルイミド
(13)の具体例としては、N−ヨウ化ブチルフタルイ
ミド、N−臭化ブチルフタルイミド、N−塩化ブチルフ
タルイミド、N−臭化プロピルフタルイミド、N−臭化
エチルフタルイミド、N−臭化メチルフタルイミド等が
挙げられる。この反応は、ジメチルホルムアミド、テト
ラヒドロフラン、ジエチルエーテル等の不活性溶媒中、
n−ブチルリチウム、リチウムジイソプロピルアミド、
水素化ナトリウム等の塩基の存在下に行われる。The above reaction will be described below step by step. (1) Step 7 1-Alkyl-4,5-diphenyl-2-imidazolidinone (9) was added to N-halogenoalkylphthalimide (1
By reacting 3), phthalimidoalkyl-
4,5-Diphenyl-2-imidazolidinone derivative (1
4) is obtained. Specific examples of the N-halogenoalkyl phthalimide (13) include N-butyl iodide phthalimide, N-butyl bromide phthalimide, N-butyl chloride phthalimide, N-propyl bromide phthalimide, N-ethyl bromide phthalimide, N- Examples include methyl bromide bromide and the like. This reaction is carried out in an inert solvent such as dimethylformamide, tetrahydrofuran, diethyl ether,
n-butyllithium, lithium diisopropylamide,
It is carried out in the presence of a base such as sodium hydride.
【0027】(2)工程8 フタルイミドアルキル−4,5−ジフェニル−2−イミ
ダゾリジノン誘導体(14)に抱水ヒドラジンを反応さ
せることによりアミノアルキル−4,5−ジフェニル−
2−イミダゾリジノン誘導体(15)が得られる。この
反応は、化合物(14)と抱水ヒドラジンをエタノー
ル、メタノール、テトラヒドロフラン等の溶媒に溶解
し、加熱することにより行われる。(2) Step 8 Aminoalkyl-4,5-diphenyl- by reacting the phthalimidoalkyl-4,5-diphenyl-2-imidazolidinone derivative (14) with hydrazine hydrate.
A 2-imidazolidinone derivative (15) is obtained. This reaction is carried out by dissolving the compound (14) and hydrazine hydrate in a solvent such as ethanol, methanol or tetrahydrofuran and heating.
【0028】(3)工程9 アミノアルキル−4,5−ジフェニル−2−イミダゾリ
ジノン誘導体(15)に塩基存在下二硫化炭素を反応さ
せ、続いて2−クロロ−1,3−ジメチルイミダゾリニ
ウムクロライドを反応させることによりチオシアナトア
ルキル−4,5−ジフェニル−2−イミダゾリジノン
(1b)が得られる。用いられる塩基としては、トリエ
チルアミン、ピリジン、N,N−ジメチルアニリン等の
有機塩基、炭酸カリウム、水酸化ナトリウム、炭酸水素
ナトリウム等の無機塩基が挙げられる。反応は、塩化メ
チレン、ジメチルホルムアミド、アセトニトリル等の不
活性溶媒中、室温あるいは冷却下に行われる。(3) Step 9 The aminoalkyl-4,5-diphenyl-2-imidazolidinone derivative (15) is reacted with carbon disulfide in the presence of a base, and then 2-chloro-1,3-dimethylimidazoli. The thiocyanatoalkyl-4,5-diphenyl-2-imidazolidinone (1b) is obtained by reacting with a nickel chloride. Examples of the base used include organic bases such as triethylamine, pyridine and N, N-dimethylaniline, and inorganic bases such as potassium carbonate, sodium hydroxide and sodium hydrogen carbonate. The reaction is carried out in an inert solvent such as methylene chloride, dimethylformamide and acetonitrile at room temperature or under cooling.
【0029】かくして得られた本発明化合物(1)を用
いて不斉炭素を有するアミン類の光学純度を分析するに
は、本発明化合物(1)に被検体であるアミン類を反応
させ、得られたチオ尿素誘導体のNMR測定を行い、各
ジアステレオマーのシグナルピークの積分値を比較すれ
ばよい。この反応は次の反応式で表される。In order to analyze the optical purity of amines having an asymmetric carbon by using the compound (1) of the present invention thus obtained, the compound (1) of the present invention is reacted with an amine as a test substance to obtain the compound. The obtained thiourea derivative may be measured by NMR and the integrated values of the signal peaks of the diastereomers may be compared. This reaction is represented by the following reaction formula.
【0030】[0030]
【化5】 Embedded image
【0031】(式中、R4 及びR5 は少なくともどちら
か一方が不斉炭素を有する有機基を示し、R1、R2 及
びlは前記と同じ)(In the formula, at least one of R 4 and R 5 represents an organic group having an asymmetric carbon, and R 1 , R 2 and l are the same as above)
【0032】この反応は、例えばトルエン、塩化メチレ
ン、テトラヒドロフラン、アセトニトリル等の不活性溶
媒中、室温〜還流温度で行われる。また、NMR測定
は、生成物を単離後又は反応液を濃縮してそのまま行う
ことができる。This reaction is carried out at room temperature to reflux temperature in an inert solvent such as toluene, methylene chloride, tetrahydrofuran or acetonitrile. Further, the NMR measurement can be carried out as it is after isolating the product or concentrating the reaction solution.
【0033】[0033]
【実施例】以下、実施例を挙げて本発明をさらに詳細に
説明するが、本発明はこれらに限定されるものではな
い。EXAMPLES Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited thereto.
【0034】製造例1 (4S,5S)−4,5−ジフ
ェニル−2−イミダゾリジノンの製造:(1S,2S)
−1,2−ジフェニル−1,2−エタンジアミン20.
0g(94mmol)、尿素6.0g(100mmol)及び水
1mlの混合物を、水を留去しながら200℃で3時間加
熱した。放冷後塩化メチレンで溶解し、溶解液を水洗後
無水硫酸マグネシウムで乾燥させ、減圧下で溶媒を留去
して白色結晶性残渣を得た。この残渣をアセトニトリル
で洗浄し、標記化合物を19.6g(収率87%)得
た。Production Example 1 Production of (4S, 5S) -4,5-diphenyl-2-imidazolidinone: (1S, 2S)
-1,2-diphenyl-1,2-ethanediamine 20.
A mixture of 0 g (94 mmol), 6.0 g of urea (100 mmol) and 1 ml of water was heated at 200 ° C. for 3 hours while distilling off water. After standing to cool, the mixture was dissolved in methylene chloride, and the solution was washed with water and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain a white crystalline residue. The residue was washed with acetonitrile to obtain 19.6 g (yield 87%) of the title compound.
【0035】 IR(νKBr max cm-1):3200, 3060, 1700, 6951 H-NMR(CDCl3)δ:4.60(2H,s), 4.93(2H,s), 7.19〜7.3
8(10H,m)IR (ν KBr max cm −1 ): 3200, 3060, 1700, 695 1 H-NMR (CDCl 3 ) δ: 4.60 (2H, s), 4.93 (2H, s), 7.19 to 7.3
8 (10H, m)
【0036】製造例2 (4S,5S)−4,5−ジフ
ェニル−1−プロピオニル−2−イミダゾリジノンの製
造:無水ジメチルホルムアミド180ml中に(4S,5
S)−4,5−ジフェニル−2−イミダゾリジノン1
7.6g(74mmol)及び水素化ナトリウム6.5g
(55% 148mmol)を加え、室温で1.5時間攪拌
した。反応液を氷冷し、プロピオン酸クロライド6.8
g(74mmol)をゆっくりと滴下し、終了後室温で1時
間攪拌を続けた。反応液を希塩酸水溶液中に加え、塩化
メチレンで抽出し、抽出液は水及び飽和炭酸水素ナトリ
ウム水溶液で順次洗浄し、無水硫酸マグネシウムで乾燥
後、減圧下溶媒を留去して25.9gの残渣を得た。こ
の残渣をシリカゲルクロマトグラフィー(溶媒 クロロ
ホルム)で精製し、標記化合物を18.3g(収率84
%)得た。Preparation Example 2 Preparation of (4S, 5S) -4,5-diphenyl-1-propionyl-2-imidazolidinone: (4S, 5 in 180 ml of anhydrous dimethylformamide.
S) -4,5-Diphenyl-2-imidazolidinone 1
7.6 g (74 mmol) and 6.5 g of sodium hydride
(55% 148 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. The reaction solution was cooled with ice and propionyl chloride 6.8.
g (74 mmol) was slowly added dropwise, and after completion, stirring was continued at room temperature for 1 hour. The reaction solution was added to dilute aqueous hydrochloric acid solution and extracted with methylene chloride. The extract solution was washed successively with water and saturated aqueous sodium hydrogen carbonate solution, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to give 25.9 g of residue. Got The residue was purified by silica gel chromatography (solvent: chloroform) to give 18.3 g of the title compound (yield 84
%)Obtained.
【0037】1H-NMR(CDCl3)δ:1.07(3H,t,J=7.5Hz),
2.91〜3.00(2H,m),4.50(1H,d,J=3.3Hz), 5.11(1H,d,J=
3.3Hz), 5.61(1H,bs),7.24〜7.41(10H,m) 1 H-NMR (CDCl 3 ) δ: 1.07 (3H, t, J = 7.5Hz),
2.91 ~ 3.00 (2H, m), 4.50 (1H, d, J = 3.3Hz), 5.11 (1H, d, J =
3.3Hz), 5.61 (1H, bs), 7.24 ~ 7.41 (10H, m)
【0038】製造例3 (4S,5S)−4,5−ジフ
ェニル−1−プロピオニル−3−プロピル−2−イミダ
ゾリジノンの製造:ジメチルホルムアミド50ml中に、
(4S,5S)−4,5−ジフェニル−1−プロピオニ
ル−2−イミダゾリジノン5.26g(17.9mmol)
及び水素化ナトリウム0.94g(55% 21.5mm
ol)を加え室温で1時間攪拌し、ナトリウム塩を調製し
た。次いで、この反応液に臭化プロピル2.42g(1
9.7mmol)をゆっくりと滴下し、終了後さらに17時
間攪拌を続けた。反応液を希塩酸水溶液中に加え塩化メ
チレンで抽出し、抽出液は水洗後無水硫酸マグネシウム
で乾燥し、減圧下に溶媒を留去して油状性残渣を得た。
この残渣をシリカゲルクロマトグラフィー(溶媒 クロ
ロホルム)にて精製し、粘稠油状物である標記化合物を
4.93g(収率82%)得た。Preparation Example 3 Preparation of (4S, 5S) -4,5-diphenyl-1-propionyl-3-propyl-2-imidazolidinone: In 50 ml of dimethylformamide,
(4S, 5S) -4,5-diphenyl-1-propionyl-2-imidazolidinone 5.26 g (17.9 mmol)
And sodium hydride 0.94g (55% 21.5mm
ol) was added and the mixture was stirred at room temperature for 1 hour to prepare a sodium salt. Next, 2.42 g of propyl bromide (1
(9.7 mmol) was slowly added dropwise, and stirring was continued for another 17 hours after the completion. The reaction solution was added to dilute aqueous hydrochloric acid solution and extracted with methylene chloride. The extract solution was washed with water and dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain an oily residue.
The residue was purified by silica gel chromatography (solvent: chloroform) to obtain 4.93 g (yield 82%) of the title compound as a viscous oil.
【0039】IR(νneat max cm-1):1725, 16901 H-NMR(CDCl3)δ:0.85(3H,t,J=7.5Hz), 1.13(3H,t,J=
7.3Hz),1.44〜1.49(2H,m), 2.69〜2.77(1H,m), 3.06(2
H,t,J=7.3Hz),3.58〜3.63(1H,m), 4.34(1H,d,J=2.9Hz),
5.06(1H,d,J=2.9Hz),7.17〜7.43(10H,m)IR (ν neat max cm -1 ): 1725, 1690 1 H-NMR (CDCl 3 ) δ: 0.85 (3H, t, J = 7.5Hz), 1.13 (3H, t, J =
7.3Hz), 1.44 to 1.49 (2H, m), 2.69 to 2.77 (1H, m), 3.06 (2
H, t, J = 7.3Hz), 3.58 ~ 3.63 (1H, m), 4.34 (1H, d, J = 2.9Hz),
5.06 (1H, d, J = 2.9Hz), 7.17〜7.43 (10H, m)
【0040】製造例4 (4S,5S)−4,5−ジフ
ェニル−1−プロピル−2−イミダゾリジノンの製造:
メタノール30ml中に(4S,5S)−4,5−ジフェ
ニル−1−プロピオニル−3−プロピル−2−イミダゾ
リジノン4.93g(14.7mmol)を溶解し、この中
に28%ナトリウムメトキシドメタノール溶液5.70
g(29.4mmol)を加え室温で20分間攪拌した。反
応液に希塩酸水溶液を加え塩化メチレンで抽出し、抽出
液は飽和炭酸水素ナトリウム水溶液及び水で順次洗浄
し、無水硫酸マグネシウムで乾燥した。次いで、減圧下
に溶媒を留去して白色結晶である標記化合物を3.57
g(収率87%)得た。Production Example 4 Production of (4S, 5S) -4,5-diphenyl-1-propyl-2-imidazolidinone:
In 30 ml of methanol was dissolved 4.93 g (14.7 mmol) of (4S, 5S) -4,5-diphenyl-1-propionyl-3-propyl-2-imidazolidinone, and 28% sodium methoxide methanol was added thereto. Solution 5.70
g (29.4 mmol) was added, and the mixture was stirred at room temperature for 20 minutes. A diluted hydrochloric acid aqueous solution was added to the reaction solution, followed by extraction with methylene chloride. The extract was washed with a saturated sodium hydrogen carbonate aqueous solution and water in that order, and dried over anhydrous magnesium sulfate. Then, the solvent was distilled off under reduced pressure to obtain 3.57 of the title compound as white crystals.
g (yield 87%) was obtained.
【0041】IR(νKBr max cm-1):3200, 17001 H-NMR(CDCl3)δ:0.81(3H,t,J=7.6Hz), 1.36〜1.43(2
H,m),2.66〜2.75(1H,m), 3.41〜3.51(1H,m), 4.36(1H,
d,J=8.8Hz),4.51(1H,d,J=8.8Hz), 4.97(1H,bs), 7.21〜
7.25(4H,m),7.26〜7.42(6H,m)IR (ν KBr max cm −1 ): 3200, 1700 1 H-NMR (CDCl 3 ) δ: 0.81 (3H, t, J = 7.6Hz), 1.36 to 1.43 (2
H, m), 2.66 ~ 2.75 (1H, m), 3.41 ~ 3.51 (1H, m), 4.36 (1H,
d, J = 8.8Hz), 4.51 (1H, d, J = 8.8Hz), 4.97 (1H, bs), 7.21〜
7.25 (4H, m), 7.26-7.42 (6H, m)
【0042】製造例5 (4S,5S)−1−ブロモア
セチル−4,5−ジフェニル−3−プロピル−2−イミ
ダゾリジノンの製造:ジメチルホルムアミド30ml中に
(4S,5S)−4,5−ジフェニル−1−プロピル−
2−イミダゾリジノン3.57g(12.8mmol)及び
水素化ナトリウム0.61g(55% 14.0mmol)
を加え室温で2.5時間攪拌し、ナトリウム塩を調製し
た。このナトリウム塩をブロモアセチルクロライド2.
81g(17.9mmol)のジメチルホルムアミド30ml
溶液中に氷冷下ゆっくりと滴下し、終了後さらに室温で
1時間攪拌した。次いで、反応液を希塩酸水溶液中に加
え塩化メチレンで抽出し、抽出液は、飽和炭酸水素ナト
リウム及び水で順次洗浄し、無水硫酸マグネシウムで乾
燥した。減圧下に溶媒を留去して得た赤色油状性残渣を
シリカゲルクロマトグラフィー(溶媒 クロロホルム)
にて精製し、粘稠油状物である標記化合物を2.74g
(収率54%)得た。Preparation 5 Preparation of (4S, 5S) -1-Bromoacetyl-4,5-diphenyl-3-propyl-2-imidazolidinone: (4S, 5S) -4,5- in 30 ml of dimethylformamide. Diphenyl-1-propyl-
3.57 g (12.8 mmol) of 2-imidazolidinone and 0.61 g (55% 14.0 mmol) of sodium hydride
Was added and stirred at room temperature for 2.5 hours to prepare a sodium salt. This sodium salt was added to bromoacetyl chloride 2.
81 g (17.9 mmol) of dimethylformamide 30 ml
The solution was slowly added dropwise to the solution under ice cooling, and after completion, the mixture was further stirred at room temperature for 1 hour. Then, the reaction solution was added to a dilute hydrochloric acid aqueous solution and extracted with methylene chloride. The extract was washed successively with saturated sodium hydrogen carbonate and water, and dried over anhydrous magnesium sulfate. The red oily residue obtained by distilling off the solvent under reduced pressure was subjected to silica gel chromatography (solvent: chloroform).
And purified by 2.74 g of the title compound as a viscous oil.
(Yield 54%) was obtained.
【0043】IR(νneat max cm-1):17201 H-NMR(CDCl3)δ:0.86(3H,t,J=7.5Hz), 1.46〜1.51(2
H,m),2.64〜2.77(1H,m), 3.48〜3.58(1H,m), 4.41(1H,
d,J=3.1Hz),4.78(1H,d,J=15.2Hz), 4.92(1H,d,J=15.2H
z), 5.06(1H,d,J=3.1Hz),7.17〜7.27(4H,m), 7.33〜7.4
3(6H,m)IR (ν neat max cm -1 ): 1720 1 H-NMR (CDCl 3 ) δ: 0.86 (3H, t, J = 7.5Hz), 1.46 to 1.51 (2
H, m), 2.64 ~ 2.77 (1H, m), 3.48 ~ 3.58 (1H, m), 4.41 (1H,
d, J = 3.1Hz), 4.78 (1H, d, J = 15.2Hz), 4.92 (1H, d, J = 15.2H
z), 5.06 (1H, d, J = 3.1Hz), 7.17 ~ 7.27 (4H, m), 7.33 ~ 7.4
3 (6H, m)
【0044】実施例1 (4S,5S)−4,5−ジフ
ェニル−1−プロピル−3−チオシアナトアセチル−2
−イミダゾリジノンの製造:メタノール30ml中に(4
S,5S)−1−ブロモアセチル−4,5−ジフェニル
−3−プロピル−2−イミダゾリジノン2.74(6.
8mmol)及びチオシアン酸カリウム0.80g(8.2
mmol)を加え2時間加熱還流した。放冷後、反応液に水
を加え塩化メチレンで抽出し、抽出液は水洗後無水硫酸
マグネシウムで乾燥した。次いで、減圧下に溶媒を留去
して得た褐色粘稠油状物2.71gをシリカゲルクロマ
トグラフィー(溶媒 n−ヘキサン/酢酸エチル)にて
精製し、標記化合物を2.27g(収率88%)得た。Example 1 (4S, 5S) -4,5-diphenyl-1-propyl-3-thiocyanatoacetyl-2
-Preparation of imidazolidinone: (4
S, 5S) -1-Bromoacetyl-4,5-diphenyl-3-propyl-2-imidazolidinone 2.74 (6.
8 mmol) and 0.80 g of potassium thiocyanate (8.2
mmol) was added and the mixture was heated under reflux for 2 hours. After cooling, water was added to the reaction solution and extracted with methylene chloride. The extract was washed with water and dried over anhydrous magnesium sulfate. Next, 2.71 g of a brown viscous oily substance obtained by distilling off the solvent under reduced pressure was purified by silica gel chromatography (solvent n-hexane / ethyl acetate) to obtain 2.27 g of the title compound (yield 88%). )Obtained.
【0045】淡黄色油状物 〔α〕27.5 D=−69.10°(c=1.00, CHCl3) UV(λMeOH max nm):208.4(ε 24200) IR(νneat max cm-1):2150, 1715, 16851 H-NMR(CDCl3)δ:0.87(3H,t,J=7.3Hz), 1.46-1.51(2H,
m),2.73〜2.81(1H,m), 3.57〜3.62(1H,m), 4.43(1H,d,J
=3.3Hz),4.50(1H,d,J=15.4Hz), 4.57(1H,d,J=15.4Hz),
5.04(1H,d,J=3.3Hz),7.16〜7.26(4H,m), 7.35〜7.46(6
H,m)13 C-NMR(CDCl3)δ:11.14, 20.32, 38.27, 43.48, 63.7
3, 65.56, 111.57,125.27, 126.15, 128.67, 129.30, 1
29.35, 129.61, 138.08, 139.58,154.17, 164.99Light yellow oil [α] 27.5 D = −69.10 ° (c = 1.00, CHCl 3 ) UV (λ MeOH max nm): 208.4 (ε 24200) IR (ν neat max cm −1 ): 2150, 1715 , 1685 1 H-NMR (CDCl 3 ) δ: 0.87 (3H, t, J = 7.3Hz), 1.46-1.51 (2H,
m), 2.73 to 2.81 (1H, m), 3.57 to 3.62 (1H, m), 4.43 (1H, d, J
= 3.3Hz), 4.50 (1H, d, J = 15.4Hz), 4.57 (1H, d, J = 15.4Hz),
5.04 (1H, d, J = 3.3Hz), 7.16 ~ 7.26 (4H, m), 7.35 ~ 7.46 (6
H, m) 13 C-NMR (CDCl 3 ) δ: 11.14, 20.32, 38.27, 43.48, 63.7
3, 65.56, 111.57, 125.27, 126.15, 128.67, 129.30, 1
29.35, 129.61, 138.08, 139.58,154.17, 164.99
【0046】製造例6 (4S,5S)−1−ブロモア
セチル−4,5−ジフェニル−3−メチル−2−イミダ
ゾリジノンの製造:ジメチルホルムアミド20ml中に製
造例1〜4と同様にして得られた(4S,5S)−4,
5−ジフェニル−1−メチル−2−イミダゾリジノン
5.90g(23.4mmol)及び水素化ナトリウム1.
12g(55% 25.7mmol)を加え室温で2.5時
間攪拌しナトリウム塩を調製した。このナトリウム塩を
ブロモアセチルクロライド5.53g(35.1mmol)
のジメチルホルムアミド20ml溶液中に氷冷下ゆっくり
と滴下し、終了後さらに室温で3時間攪拌した。以下、
製造例5と同様の操作を行い、標記化合物を5.04g
(収率58%)得た。Preparation Example 6 Preparation of (4S, 5S) -1-bromoacetyl-4,5-diphenyl-3-methyl-2-imidazolidinone: Obtained in the same manner as in Preparation Examples 1 to 4 in 20 ml of dimethylformamide. (4S, 5S) -4,
5-Diphenyl-1-methyl-2-imidazolidinone 5.90 g (23.4 mmol) and sodium hydride 1.
12 g (55% 25.7 mmol) was added and the mixture was stirred at room temperature for 2.5 hours to prepare a sodium salt. 5.53 g (35.1 mmol) of this sodium salt was added to bromoacetyl chloride.
Was slowly added dropwise to a 20 ml solution of dimethylformamide under ice-cooling, and after completion, the mixture was further stirred at room temperature for 3 hours. Less than,
The same operation as in Production Example 5 was carried out to obtain 5.04 g of the title compound.
(Yield 58%) was obtained.
【0047】実施例2 (4S,5S)−4,5−ジフ
ェニル−1−メチル−3−チオシアナトアセチル−2−
イミダゾリジノンの製造:メタノール50ml中に(4
S,5S)−1−ブロモアセチル−4,5−ジフェニル
−3−メチル−2−イミダゾリジノン4.52g(1
2.1mmol)及びチオシアン酸カリウム1.31g(1
3.5mmol)を加え4時間加熱還流した。以下、実施例
1と同様の操作を行い標記化合物を3.89g(収率9
2%)得た。Example 2 (4S, 5S) -4,5-diphenyl-1-methyl-3-thiocyanatoacetyl-2-
Preparation of imidazolidinone: In 50 ml of methanol (4
S, 5S) -1-Bromoacetyl-4,5-diphenyl-3-methyl-2-imidazolidinone 4.52 g (1
2.1 mmol) and 1.31 g of potassium thiocyanate (1
(3.5 mmol) was added and the mixture was heated under reflux for 4 hours. Thereafter, the same operation as in Example 1 was carried out to obtain 3.89 g of the title compound (yield: 9
2%).
【0048】m.p. 77.8〜78.6℃ 〔α〕23.7 D=−60.5°(c=1.00, CHCl3) UV(λMeOH max nm):209.6(ε 23300) IR(νKBr max cm-1):2150, 1715, 16851 H-NMR(CDCl3)δ:2.82(3H,s), 4.37(1H,d,J=3.7Hz),4.
49(1H,d,J=15.4Hz), 4.57(1H,d,J=15.4Hz), 5.04(1H,d,
J=3.7Hz),7.16〜7.26(4H,m), 7.35〜7.46(6H,m)13 C-NMR(CDCl3)δ:29.09, 38.22, 63.67, 67.72, 111.
61, 125.38,126.12, 128.60, 129.23, 129.28, 129.58,
137.57, 139.25, 154.15,164.96Mp 77.8 to 78.6 ° C [α] 23.7 D = -60.5 ° (c = 1.00, CHCl 3 ) UV (λ MeOH max nm): 209.6 (ε 23300) IR (ν KBr max cm -1 ): 2150, 1715, 1685 1 H-NMR (CDCl 3 ) δ: 2.82 (3H, s), 4.37 (1H, d, J = 3.7Hz), 4.
49 (1H, d, J = 15.4Hz), 4.57 (1H, d, J = 15.4Hz), 5.04 (1H, d,
J = 3.7Hz), 7.16 to 7.26 (4H, m), 7.35 to 7.46 (6H, m) 13 C-NMR (CDCl 3 ) δ: 29.09, 38.22, 63.67, 67.72, 111.
61, 125.38, 126.12, 128.60, 129.23, 129.28, 129.58,
137.57, 139.25, 154.15,164.96
【0049】製造例7 (4S,5S)−4,5−ジフ
ェニル−1−メチル−3−(4−フタルイミドブチル)
−2−イミダゾリジノンの製造:N,N−ジメチルホル
ムアミド10ml中に水素化ナトリウム0.28g(55
% 6.48mmol)及び(4S,5S)−4,5−ジフ
ェニル−1−メチル−2−イミダゾリジノン1.36g
(5.40mmol)を加え室温で20分間攪拌しナトリウ
ム塩を調製した。次いで、反応液にN−(4−ブロモブ
チル)フタルイミド1.52g(5.40mmol)を加え
室温で16時間攪拌した。反応液を希塩酸水溶液中に加
え、塩化メチレンで抽出し、抽出液は水洗後無水硫酸マ
グネシウムで乾燥し、減圧下に溶媒を留去して油状性残
渣を得た。この残渣をシリカゲルクロマトグラフィー
(溶媒 クロロホルム)にて精製し、標記化合物を1.
76g(収率72%)得た。Production Example 7 (4S, 5S) -4,5-diphenyl-1-methyl-3- (4-phthalimidobutyl)
Preparation of 2-imidazolidinone: 0.28 g (55%) of sodium hydride in 10 ml of N, N-dimethylformamide.
% 6.48 mmol) and (4S, 5S) -4,5-diphenyl-1-methyl-2-imidazolidinone 1.36 g
(5.40 mmol) was added and the mixture was stirred at room temperature for 20 minutes to prepare a sodium salt. Then, 1.52 g (5.40 mmol) of N- (4-bromobutyl) phthalimide was added to the reaction solution, and the mixture was stirred at room temperature for 16 hours. The reaction solution was added to a dilute aqueous hydrochloric acid solution and extracted with methylene chloride. The extract solution was washed with water and dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain an oily residue. This residue was purified by silica gel chromatography (solvent: chloroform) to give 1.
76 g (yield 72%) was obtained.
【0050】IR(νneat max cm-1):1750, 17051 H-NMR(CDCl3)δ:1.36〜1.39(2H,m), 1.59〜1.66(2H,
m), 2.66(3H,s),2.86〜2.88(1H,m), 3.43〜3.48(1H,m),
3.58(2H,t,J=7.3Hz),4.09(1H,d,J=8.0Hz), 4.19(1H,d,
J=8.0Hz), 7.09〜7.36(10H,m),7.66〜7.69(2H,m), 7.78
〜7.81(2H,m)IR (ν neat max cm -1 ): 1750, 1705 1 H-NMR (CDCl 3 ) δ: 1.36 to 1.39 (2H, m), 1.59 to 1.66 (2H,
m), 2.66 (3H, s), 2.86 ~ 2.88 (1H, m), 3.43 ~ 3.48 (1H, m),
3.58 (2H, t, J = 7.3Hz), 4.09 (1H, d, J = 8.0Hz), 4.19 (1H, d,
J = 8.0Hz), 7.09 ~ 7.36 (10H, m), 7.66 ~ 7.69 (2H, m), 7.78
~ 7.81 (2H, m)
【0051】製造例8 (4S,5S)−1−(4−ア
ミノブチル)−4,5−ジフェニル−3−メチル−2−
イミダゾリジノンの製造:エタノール100ml中に(4
S,5S)−4,5−ジフェニル−1−メチル−3−
(4−フタルイミドブチル)−2−イミダゾリジノン
1.76g(3.89mmol)及び抱水ヒドラジン5.0
g(99.8mmol)を加え、3時間加熱還流した。放冷
後析出晶を濾別し、濾液に水酸化ナトリウム水溶液を加
え、塩化メチレンで抽出し、抽出液は水洗後無水硫酸ナ
トリウムで乾燥した。次いで、減圧下に溶媒を留去して
標記化合物を1.20g(収率100%)得た。Production Example 8 (4S, 5S) -1- (4-aminobutyl) -4,5-diphenyl-3-methyl-2-
Preparation of imidazolidinone: In 100 ml of ethanol (4
S, 5S) -4,5-Diphenyl-1-methyl-3-
(4-phthalimidobutyl) -2-imidazolidinone 1.76 g (3.89 mmol) and hydrazine hydrate 5.0
g (99.8 mmol) was added, and the mixture was heated under reflux for 3 hours. After cooling, the precipitated crystals were separated by filtration, an aqueous sodium hydroxide solution was added to the filtrate, and the mixture was extracted with methylene chloride. The extract was washed with water and dried over anhydrous sodium sulfate. Then, the solvent was distilled off under reduced pressure to obtain 1.20 g (yield 100%) of the title compound.
【0052】IR(νneat max cm-1):17001 H-NMR(CDCl3)δ:1.26〜1.42(6H,m), 2.60〜2.65(2H,
m), 2.68(3H,s),2.74〜2.81(1H,m), 3.44〜3.50(1H,m),
4.09(1H,d,J=8.3Hz),4.21(1H,d,J=8.3Hz), 7.08〜7.36
(10H,m)IR (ν neat max cm -1 ): 1700 1 H-NMR (CDCl 3 ) δ: 1.26 to 1.42 (6H, m), 2.60 to 2.65 (2H,
m), 2.68 (3H, s), 2.74 ~ 2.81 (1H, m), 3.44 ~ 3.50 (1H, m),
4.09 (1H, d, J = 8.3Hz), 4.21 (1H, d, J = 8.3Hz), 7.08 ~ 7.36
(10H, m)
【0053】実施例3 (4S,5S)−4,5−ジフ
ェニル−1−メチル−3−(4−チオシアナトブチル)
−2−イミダゾリジノンの製造:塩化メチレン20ml中
に、(4S,5S)−1−(4−アミノブチル)−4,
5−ジフェニル−3−メチル−2−イミダゾリジノン
1.21g(3.92mmol)、二硫化炭素0.33g
(4.31mmol)及びトリエチルアミン1.38g(1
3.71mmol)を加え室温で2.5時間攪拌した。次い
で、反応液に2−クロロ−1,3−ジメチルイミダゾリ
ニウムクロライド0.79g(4.70mmol)を加え室
温で16時間攪拌した。反応液に水を加え、塩化メチレ
ンで抽出し、抽出液は水洗後無水硫酸マグネシウムで乾
燥し、減圧下に溶媒を留去して油状性残渣を得た。この
残渣をシリカゲルクロマトグラフィー(溶媒 n−ヘキ
サン/酢酸エチル)にて精製し標記化合物を1.29g
(収率90%)得た。Example 3 (4S, 5S) -4,5-diphenyl-1-methyl-3- (4-thiocyanatobutyl)
Preparation of 2-imidazolidinone: (4S, 5S) -1- (4-aminobutyl) -4, in 20 ml of methylene chloride
1.21 g (3.92 mmol) of 5-diphenyl-3-methyl-2-imidazolidinone, 0.33 g of carbon disulfide
(4.31 mmol) and 1.38 g of triethylamine (1
(3.71 mmol) was added and the mixture was stirred at room temperature for 2.5 hours. Then, 0.79 g (4.70 mmol) of 2-chloro-1,3-dimethylimidazolinium chloride was added to the reaction solution, and the mixture was stirred at room temperature for 16 hours. Water was added to the reaction solution, which was extracted with methylene chloride. The extract was washed with water and dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to give an oily residue. The residue was purified by silica gel chromatography (solvent n-hexane / ethyl acetate) to give 1.29 g of the title compound.
(Yield 90%) was obtained.
【0054】IR(νneat max cm-1):2090, 16951 H-NMR(CDCl3)δ:1.42〜1.67(4H,m), 2.69(3H,s), 2.8
7〜2.94(1H,m),3.40〜3.47(3H,m), 4.13(1H,d,J=8.0H
z), 4.19(1H,d,J=8.0Hz),7.08〜7.37(10H,m)IR (ν neat max cm -1 ): 2090, 1695 1 H-NMR (CDCl 3 ) δ: 1.42 to 1.67 (4H, m), 2.69 (3H, s), 2.8
7 to 2.94 (1H, m), 3.40 to 3.47 (3H, m), 4.13 (1H, d, J = 8.0H
z), 4.19 (1H, d, J = 8.0Hz), 7.08〜7.37 (10H, m)
【0055】実施例4 1,2−ジフェニルエチルアミ
ンの光学異性体分析:トルエン5ml中に(4S,5S)
−4,5−ジフェニル−1−メチル−3−(4−チオシ
アナトブチル)−2−イミダゾリジノン143mg(0.
39mmol)及び1,2−ジフェニルエチルアミン77mg
(0.39mmol)を加え室温で24時間攪拌した。次い
で、減圧下に溶媒を留去して得た残渣をシリカゲルクロ
マトグラフィー(溶媒 トルエン/酢酸エチル)にて精
製し、ジアステレオマーの等量混合物である(4S,5
S)−4,5−ジフェニル−1−〔4−(3−(1,2
−ジフェニルエチル)チオウレイド〕ブチル〕−3−メ
チル−2−イミダゾリジノン(IR(νneat max cm-1):33
00, 1670)を得た。この混合物を核磁気共鳴スペクトル
分析(300MHz, CDCl3)したところ、2.64ppm と
2.68ppm にS,S,S体とS,S,R体のそれぞれ
のメチル基のピーク(等量)を認めた。EXAMPLE 4 Optical isomer analysis of 1,2-diphenylethylamine: (4S, 5S) in 5 ml of toluene.
145 mg of 4,5-diphenyl-1-methyl-3- (4-thiocyanatobutyl) -2-imidazolidinone (0.
39 mmol) and 1,2-diphenylethylamine 77 mg
(0.39 mmol) was added and the mixture was stirred at room temperature for 24 hours. Then, the residue obtained by distilling off the solvent under reduced pressure was purified by silica gel chromatography (solvent: toluene / ethyl acetate) to obtain an equal mixture of diastereomers (4S, 5).
S) -4,5-diphenyl-1- [4- (3- (1,2
-Diphenylethyl) thioureido] butyl] -3-methyl-2-imidazolidinone (IR (ν neat max cm -1 ): 33
00, 1670). When this mixture was analyzed by nuclear magnetic resonance spectroscopy (300MHz, CDCl 3 ), peaks (equal amounts) of the methyl groups of S, S, S and S, S, R were detected at 2.64ppm and 2.68ppm. Admitted.
【0056】実施例5 1−(1−ナフチル)エチルア
ミンの光学異性体分析 ベンゼン10ml中に(4S,5S)−4,5−ジフェニ
ル−1−メチル−3−(4−チオシアナトブチル)−2
−イミダゾリジノン310mg(0.85mmol)及び1−
(1−ナフチル)エチルアミン145mg(0.85mmo
l)を加え室温で24時間攪拌した。次いで、減圧下に
溶媒を留去して得た残渣をシリカゲルクロマトグラフィ
ー(溶媒 トルエン/酢酸エチル)にて精製し、ジアス
テレオマーの等量混合物である(4S,5S)−4,5
−ジフェニル−1−〔4−〔3−〔1−(1−ナフチ
ル)エチル〕チオウレイド〕ブチル〕−3−メチル−2
−イミダゾリジノン(IR(νneat max cm-1):3310, 167
0)を得た。この混合物を核磁気共鳴スペクトル分析(3
00MHz, CDCl3)したところ、2.46ppm と2.50pp
m にS,S,S体とS,S,R体のそれぞれのメチル基
のピーク(等量)を認めた。Example 5 Analysis of optical isomers of 1- (1-naphthyl) ethylamine (4S, 5S) -4,5-diphenyl-1-methyl-3- (4-thiocyanatobutyl) -in 10 ml of benzene. Two
-Imidazolidinone 310 mg (0.85 mmol) and 1-
(1-Naphthyl) ethylamine 145 mg (0.85 mmo
l) was added and the mixture was stirred at room temperature for 24 hours. Then, the solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (solvent: toluene / ethyl acetate) to obtain an equivalent mixture of diastereomers (4S, 5S) -4,5.
-Diphenyl-1- [4- [3- [1- (1-naphthyl) ethyl] thioureido] butyl] -3-methyl-2
-Imidazolidinone (IR (ν neat max cm -1 ): 3310, 167
0). This mixture was analyzed by nuclear magnetic resonance spectroscopy (3
00MHz, CDCl 3 ) 2.46ppm and 2.50pp
At m, peaks (equal amounts) of S, S, S isomer and S, S, R isomer, respectively, were observed.
【0057】[0057]
【発明の効果】本発明化合物(1)を用いれば、簡便な
操作で正確に不斉炭素を有するアミン類の光学純度を分
析決定することができる。By using the compound (1) of the present invention, the optical purity of amines having an asymmetric carbon can be accurately analyzed and determined by a simple operation.
Claims (3)
を示し、lは0又は1の数を示し、*は不斉炭素の位置
を示す)で表される光学活性な4,5−ジフェニル−2
−イミダゾリジノン誘導体。1. The following general formula (1): [Wherein R 1 represents an alkyl group, R 2 represents an alkylene group, l represents a number of 0 or 1, and * represents a position of an asymmetric carbon]. -Diphenyl-2
-Imidazolidinone derivatives.
−イミダゾリジノン誘導体を含有することを特徴とする
不斉炭素を有するアミン類の光学純度分析用試薬。2. The 4,5-diphenyl-2 according to claim 1,
-A reagent for optical purity analysis of amines having an asymmetric carbon, characterized by containing an imidazolidinone derivative.
ェニル−2−イミダゾリジノン誘導体に不斉炭素を有す
るアミン類を反応させ、得られるチオ尿素誘導体を核磁
気共鳴スペクトル分析に付すことを特徴とする不斉炭素
を有するアミン類の光学純度分析法。3. The optically active 4,5-diphenyl-2-imidazolidinone derivative according to claim 1 is reacted with an amine having an asymmetric carbon, and the resulting thiourea derivative is subjected to nuclear magnetic resonance spectrum analysis. An optical purity analysis method for amines having an asymmetric carbon, characterized in that
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8078684A JPH09268178A (en) | 1996-04-01 | 1996-04-01 | Optically active 4,5-diphenyl-2-imidazolidinone derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8078684A JPH09268178A (en) | 1996-04-01 | 1996-04-01 | Optically active 4,5-diphenyl-2-imidazolidinone derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09268178A true JPH09268178A (en) | 1997-10-14 |
Family
ID=13668707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8078684A Pending JPH09268178A (en) | 1996-04-01 | 1996-04-01 | Optically active 4,5-diphenyl-2-imidazolidinone derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH09268178A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014159418A (en) * | 2010-03-12 | 2014-09-04 | Nippon Soda Co Ltd | Method of producing tetrazolyloxime derivative |
-
1996
- 1996-04-01 JP JP8078684A patent/JPH09268178A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014159418A (en) * | 2010-03-12 | 2014-09-04 | Nippon Soda Co Ltd | Method of producing tetrazolyloxime derivative |
US8962848B2 (en) | 2010-03-12 | 2015-02-24 | Nippon Soda Co., Ltd. | Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
US9000178B2 (en) | 2010-03-12 | 2015-04-07 | Nippon Soda Co., Ltd. | Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
US9012653B2 (en) | 2010-03-12 | 2015-04-21 | Nippon Soda Co., Ltd. | Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
US9018385B2 (en) | 2010-03-12 | 2015-04-28 | Nippon Soda Co., Ltd. | Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Murakata et al. | Stereoselective reactions. 30. Enantioselective alkylation of the lithium enolates of six-membered cyclic ketones using tetradentate chiral amines in the presence of lithium bromide | |
JP3563643B2 (en) | Imidazoline compounds, intermediates thereof, and methods for producing them, and methods for producing azepine compounds and salts thereof | |
US20100256414A1 (en) | Process for the preparation of chirally pure nateglinide | |
JPH09268178A (en) | Optically active 4,5-diphenyl-2-imidazolidinone derivative | |
JP4510614B2 (en) | Optically active β-aminoketone, optically active 1,3-aminoalcohol, and production method thereof | |
US7161024B2 (en) | Process for the preparation and purification of 2-(alkoxyalkylidene)-3-ketoalkanoic acid esters from 3-ketoalkanoic acid esters | |
US5808088A (en) | Preparation of mibefradil via an acetamide anion | |
JPS6036457A (en) | Manufacture of 3-phenoxy-1-azetidines and carboxamide derivatives | |
HU220971B1 (en) | Process for producing 0-(3-amino-2-hidroxy-propyl)-hidroxim acid halogenids | |
JPH02306942A (en) | Production of optically active phenylethylamine derivative | |
CN103214394B (en) | A kind of Alkynyl imine derivative | |
JP3745405B2 (en) | Method for producing glutaconaldehyde dianil derivative | |
JP4093608B2 (en) | Process for producing optically active 2-phenoxypropionic acid | |
JP3552260B2 (en) | Optical resolution of 1-amino-2-indanols | |
JP3432880B2 (en) | Preparation of optically active azaspiro compounds | |
MXPA02004873A (en) | Method for production of benzofuranone oximes. | |
JP2717257B2 (en) | Production method of optically active compound | |
US20040030145A1 (en) | Optically active B-aminoketones, optically active 1,3-amino alcohols and processes for preparing them | |
CN117003682A (en) | Preparation method of polysubstituted 3-dihydropyrrole compound | |
JPS5821628B2 (en) | Tetrazole | |
JPH08109190A (en) | Oxaazacyclophosphamide derivative effective for determining optical purity and steric configuration of amines and alcohols | |
EP1484314A1 (en) | Process for production of optically active beta-phenylalanine derivatives | |
JPS59199684A (en) | Manufacture of 3-benzothienylglycins | |
JPH0597735A (en) | Production of optically active secondary alcohol | |
JPH1077290A (en) | Diazacyclophosphamide derivative effective in determining optical purity and steric configuration of amines and alcohols |